The Global COVID-19 Vaccination Strategy aims to inoculate 40 percent of people in all countries by the end of the year, and 70 percent by the middle of 2022.
WHO had previously pressed governments to vaccinate 10 per cent of the world’s people by the end of last month. However, more than 55 countries, mainly in Africa and the Middle East, missed the target.
“Without a coordinated, equitable approach, a reduction of cases in any one country will not be sustained over time. For everyone’s sake, we must urgently bring all countries to a high level of vaccination coverage,” he said, speaking from New York.
A ‘two-track pandemic’
The new strategy requires 11 billion vaccines to be made available, to defeat what the UN agency has labelled “a two-track pandemic”.
Even though nearly 6.5 billion doses have been administered globally as of the end of September, and almost one-third of the world’s population is fully inoculated, vaccine inequity persists.
Meanwhile, less than half of one per cent of doses have gone to low-income countries. “In Africa, less than five per cent of people are fully vaccinated,” he added.
Vaccines for all
Global vaccine production currently stands at 1.5 billion doses per month, meaning “there is enough supply to achieve our targets, provided they are distributed equitably,” said Tedros.
“This is not a supply problem; it’s an allocation problem,” he added.
The strategy calls for a three-step approach to vaccination, starting with protecting older people, health workers and high-risk groups of all ages. All adults in every country would be next, followed by adolescents.
While financing has been secured to procure most of the required vaccines for poorer countries, including through the COVAX solidarity initiative and the African Vaccine Acquisition Trust (AVAT), additional investment is needed.
‘We have the tools’
“We call on vaccine manufacturers to prioritize and fulfil contracts with COVAX and AVAT as a matter of urgency, to be more transparent on what is going where, and to share know-how and non-exclusive licenses to enable all regions to increase manufacturing capacity,” said Tedros.
Countries that produce vaccines should allow for cross-border flow of finished vaccines and raw materials, and facilitate sharing of knowledge, technology and licenses. Governments were also urged to update their national vaccine targets and plans “to guide manufacturing investment and vaccine distribution”.
Tedros said the strategy can be achieved if the countries and companies that control vaccine supply prioritize COVAX and the AVAT, both for vaccine delivery and donations.
“We have the tools to bring the pandemic under control, if we use them properly and share them fairly,” he said.